GZMK and breast cancer: Among all breast cancer patients (n = 1,879), those in the high GZMK expression group (n = 935) had significantly better OS compared to those in the low expression group (n = 944), with statistical significance (HR = 0.58 [0.48–0.71], P < 0.001) (Figure S3A).